US CDC vaccine panel postpones vote on RSV therapies
Tweet
Share
E-mail
A sign of the CDC is seen on a podium during the meeting of the members of the Advisory Committee on Immunization Practices, as the U.S. Centers for Disease Control and Prevention's (CDC) advisory panel for vaccines convenes in Atlanta, Georgia, U.S. June
(Reuters) -The U.S. Centers for Disease Control and Prevention's revamped vaccine advisory panel on Wednesday postponed its vote on the use of respiratory syncytial virus therapies to Thursday.
The panel, which has convened for a closely watched two-day meeting, was discussing the use of AstraZeneca and Sanofi's Beyfortus and Merck's Enflonsia.
(Reporting by Christy Santhosh and Bhanvi Satija in Bengaluru; Editing by Maju Samuel)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RedBird Capital to acquire majority stake in Puck at $250 million valuation, memo says
- Beset by far-right rival, Italy's Meloni tightens foreign pupil rules
- Russia says strikes hit Ukrainian military-linked facilities, vessels
Create E-mail Alert Related Categories
ReutersSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
